For research use only
| Cat No. | ABC-TC3466 |
| Product Type | Dermal Cells |
| Cell Type | Endothelial |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Dermal |
| Disease | Normal |
| Storage | Liquid Nitrogen |
HMVEC-d Neo Der MV Pooled Cells provide a neonatal-derived dermal endothelial model for angiogenesis, vascular biology, and inflammation-related research.
HMVEC-d Neo Der MV Pooled Cells are primary endothelial cells isolated from small vessels within skin tissue from either adults or neonatal foreskins. Cryopreserved after initial culture, these cells exhibit typical adherent growth and retain critical microvascular functions, including regulation of vascular permeability, angiogenesis, and leukocyte trafficking. They are implicated in diabetic microangiopathy, contributing to retinopathy/nephropathy, chronic inflammation driving psoriasis progression through endothelial activation, and impaired wound healing due to dysregulated VEGF signaling in hyperglycemia. Due to their sensitivity, repeated freezing and thawing should be avoided during culture. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | HMVEC-d Neonatal Dermal Microvascular Endothelial Cells Pooled, Neonatal Dermal MVECs Pool, HMVEC-d Neo Pooled Cells, Human Neonatal Skin MVECs Pooled, Dermal Microvascular ECs Neonatal Pool |
| Species | Human |
| Cat.No | ABC-TC3466 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Endothelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Dermal |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Dermal Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
HMVEC-d Neo Der MV Pooled Cells serve as a standardized in vitro microvascular model to study the pathogenesis of diabetic dermal microangiopathy. Researchers can utilize them in investigating hyperglycemia-induced disruption of VE-cadherin junctions, leukocyte-endothelial adhesion cascades, and chronic inflammatory responses. Such studies reveal mechanisms of vascular leakage and chronic inflammation.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).